BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

384 related articles for article (PubMed ID: 19798694)

  • 21. GATA3 inhibits breast cancer metastasis through the reversal of epithelial-mesenchymal transition.
    Yan W; Cao QJ; Arenas RB; Bentley B; Shao R
    J Biol Chem; 2010 Apr; 285(18):14042-51. PubMed ID: 20189993
    [TBL] [Abstract][Full Text] [Related]  

  • 22. GATA3 recruits UTX for gene transcriptional activation to suppress metastasis of breast cancer.
    Yu W; Huang W; Yang Y; Qiu R; Zeng Y; Hou Y; Sun G; Shi H; Leng S; Feng D; Chen Y; Wang S; Teng X; Yu H; Wang Y
    Cell Death Dis; 2019 Nov; 10(11):832. PubMed ID: 31685800
    [TBL] [Abstract][Full Text] [Related]  

  • 23. ELK3-GATA3 axis modulates MDA-MB-231 metastasis by regulating cell-cell adhesion-related genes.
    Kim KS; Kim J; Oh N; Kim MY; Park KS
    Biochem Biophys Res Commun; 2018 Apr; 498(3):509-515. PubMed ID: 29510139
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Utility of GATA-3 in the work-Up of breast adenocarcinoma and its differential diagnosis in serous effusions:: A Cell-Block Microarray Study.
    El Hag MI; Ha J; Farag R; El Hag AM; Michael CW
    Diagn Cytopathol; 2016 Sep; 44(9):731-6. PubMed ID: 27338760
    [TBL] [Abstract][Full Text] [Related]  

  • 25. CDK inhibitor p18(INK4c) is a downstream target of GATA3 and restrains mammary luminal progenitor cell proliferation and tumorigenesis.
    Pei XH; Bai F; Smith MD; Usary J; Fan C; Pai SY; Ho IC; Perou CM; Xiong Y
    Cancer Cell; 2009 May; 15(5):389-401. PubMed ID: 19411068
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Higher levels of GATA3 predict better survival in women with breast cancer.
    Yoon NK; Maresh EL; Shen D; Elshimali Y; Apple S; Horvath S; Mah V; Bose S; Chia D; Chang HR; Goodglick L
    Hum Pathol; 2010 Dec; 41(12):1794-801. PubMed ID: 21078439
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Mutant GATA3 Actively Promotes the Growth of Normal and Malignant Mammary Cells.
    Emmanuel N; Lofgren KA; Peterson EA; Meier DR; Jung EH; Kenny PA
    Anticancer Res; 2018 Aug; 38(8):4435-4441. PubMed ID: 30061207
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Strong androgen receptor expression can aid in distinguishing GATA3+ metastases.
    Boto A; Harigopal M
    Hum Pathol; 2018 May; 75():63-70. PubMed ID: 29408697
    [TBL] [Abstract][Full Text] [Related]  

  • 29.
    Shahi P; Wang CY; Lawson DA; Slorach EM; Lu A; Yu Y; Lai MD; Gonzalez Velozo H; Werb Z
    Proc Natl Acad Sci U S A; 2017 Mar; 114(12):3169-3174. PubMed ID: 28258171
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The androgen receptor interacts with GATA3 to transcriptionally regulate a luminal epithelial cell phenotype in breast cancer.
    Hosseinzadeh L; Kikhtyak Z; Laven-Law G; Pederson SM; Puiu CG; D'Santos CS; Lim E; Carroll JS; Tilley WD; Dwyer AR; Hickey TE
    Genome Biol; 2024 Feb; 25(1):44. PubMed ID: 38317241
    [TBL] [Abstract][Full Text] [Related]  

  • 31. GATA-3 maintains the differentiation of the luminal cell fate in the mammary gland.
    Kouros-Mehr H; Slorach EM; Sternlicht MD; Werb Z
    Cell; 2006 Dec; 127(5):1041-55. PubMed ID: 17129787
    [TBL] [Abstract][Full Text] [Related]  

  • 32. GATA3 in Breast Cancer: Tumor Suppressor or Oncogene?
    Takaku M; Grimm SA; Wade PA
    Gene Expr; 2015; 16(4):163-8. PubMed ID: 26637396
    [TBL] [Abstract][Full Text] [Related]  

  • 33. GATA Binding Protein 3 Boosts Extracellular ATP Hydrolysis and Inhibits Metastasis of Breast Cancer by Up-regulating Ectonucleoside Triphosphate Diphosphohydrolase 3.
    Li M; Qi Y; Chen M; Wang Z; Zeng D; Xiao Y; Li S; Lin H; Wei X; Zhang G
    Int J Biol Sci; 2019; 15(12):2522-2537. PubMed ID: 31754326
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Co-expression of transcription factor AP-2beta (TFAP2B) and GATA3 in human mammary epithelial cells with intense, apicobasal immunoreactivity for CK8/18.
    Raap M; Gierendt L; Werlein C; Kuehnle E; Kreipe HH; Christgen M
    J Mol Histol; 2021 Dec; 52(6):1257-1264. PubMed ID: 34117603
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The impact of the effectiveness of GATA3 as a prognostic factor in breast cancer.
    Fararjeh AS; Tu SH; Chen LC; Liu YR; Lin YK; Chang HL; Chang HW; Wu CH; Hwang-Verslues WW; Ho YS
    Hum Pathol; 2018 Oct; 80():219-230. PubMed ID: 29902578
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Progesterone receptor activation downregulates GATA3 by transcriptional repression and increased protein turnover promoting breast tumor growth.
    Izzo F; Mercogliano F; Venturutti L; Tkach M; Inurrigarro G; Schillaci R; Cerchietti L; Elizalde PV; Proietti CJ
    Breast Cancer Res; 2014 Dec; 16(6):491. PubMed ID: 25479686
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The Novel Marker GATA3 is Significantly More Sensitive Than Traditional Markers Mammaglobin and GCDFP15 for Identifying Breast Cancer in Surgical and Cytology Specimens of Metastatic and Matched Primary Tumors.
    Sangoi AR; Shrestha B; Yang G; Mego O; Beck AH
    Appl Immunohistochem Mol Morphol; 2016 Apr; 24(4):229-37. PubMed ID: 25906123
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Arsenic reduces the GATA3 expression associated with an increase in proliferation and migration of mammary epithelial cell line MCF-10A.
    Vergara-Gerónimo CA; León-Del-Rio A; Rodríguez-Dorantes M; Camacho-Carranza R; Ostrosky-Wegman P; Salazar AM
    Toxicol Appl Pharmacol; 2023 Aug; 472():116573. PubMed ID: 37269932
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Identification of GATA3 as a breast cancer prognostic marker by global gene expression meta-analysis.
    Mehra R; Varambally S; Ding L; Shen R; Sabel MS; Ghosh D; Chinnaiyan AM; Kleer CG
    Cancer Res; 2005 Dec; 65(24):11259-64. PubMed ID: 16357129
    [TBL] [Abstract][Full Text] [Related]  

  • 40. GATA3 Truncating Mutations Promote Cistromic Re-Programming In Vitro, but Not Mammary Tumor Formation in Mice.
    Cornelissen LM; de Bruijn R; Henneman L; Kim Y; Zwart W; Jonkers J
    J Mammary Gland Biol Neoplasia; 2019 Sep; 24(3):271-284. PubMed ID: 31218575
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.